Fred Ting

Associate Dean, USLS College of Medicine / Co-Chair, Training Committee of the Philippine Society of Medical Oncology. @oncologyph | Opinions mine.

[Fred Ting @fredtingmd]

Happy to have shared our story in this part of the world. ❤️

[Journal of Clinical Oncology @JCO_ASCO]

Art of Oncology: The road less traveled - serving the underserved, by @fredtingmd https://t.co/Ct9XlLJGCw #JCO

[Rebecca Shatsky, MD @Dr_RShatsky]

Say it louder for the folks in the back!! I get so mad when I do second opinions for premenopausal patients with node positive disease who were given only tamoxifen because their oncologists told them there “wasn’t a big difference” between tam and OA/AI. There is!!!!!

[Fred Ting @fredtingmd]

@BioMedCentral Cancer recently launched the Cancer Control in LMICs Collection. Please feel free to inquire or submit your manuscipts!

https://t.co/fMOtanmj8S

[Edward Christopher "Chris" Dee, MD @EChrisDee]

📜 In @LancetRH_Americ, we draw attention to the #political #determinants of #cancer #health in the context of national cancer control plans

🙏 #patient #advocate Kara Magsanoc-Alikpala & Drs @FabioMoraesMD @Jonas_Willmann @FredTingMD @Erin_Feliciano

🔗 https://t.co/K9WX0mneRQ

[Pankaj Kumar Panda @pankajpanda86]

Privileged and honoured to present our work on Improving Access to Clinical Trials and Novel Therapeutics for Advanced Solid Tumours (ASTER Study) on behalf of @apoddc at #ESMOTATAsia25
@danieltanmd @herbloong @DrBenTran Dr Tira Tan
Grateful for @myESMO Merit Travel Grant!

[Fred Ting @fredtingmd]

Let us please have our families, friends, and ourselves screened! Colonoscopy is recommended to start at 45 years old. 🙏
.
Link to full paper: https://t.co/omGh5qg7AS
.
#CancerCare
#CancerIsNotADeathSentence
#ThereIsAlwaysHope

[Fred Ting @fredtingmd]

Happy to be part of this study but at the same time a bit worried about the results.
.
Early Onset Colorectal Cancer incidence and mortality are expected to increase by approximately 20% from 2022 to 2050.

[Fred Ting @fredtingmd]

Low Human Development Index countries, Eastern Africa, Western Africa, and Middle Africa are projected to have more than double the number of cases and deaths (119.4% to 152.4% and 119.9% to 153.2%).
.

[Fred Ting @fredtingmd]

Link to full paper: https://t.co/rNV27Gizcg

[Fred Ting @fredtingmd]

Was finally able to get a hard copy of my @JAMAOnc piece entitled “Persons With Cancer Rather Than Cancer Patients—Semantics Matter,”

[Fred Ting @fredtingmd]

Thank you, @EChrisDee , for making this happen and bringing the paper all the way from the US!

[Cristiane D Bergerot, PhD, FASCO @crisbergerot]

Great catching up with @JamesFanWu and @fredtingmd at #ASCO25! Always a pleasure to chat and share laughs while presenting our posters. Grateful for this brilliant community! 📸✨

[Edward Christopher "Chris" Dee, MD @EChrisDee]

Led by Marcky Antonio & @StephanieWang04 of @Harvard, mentored by @Erin_Feliciano, we present, "Financial toxicity of hemophilia care in Southeast Asian countries" in @LancetRH_SEAsia

🇧🇳🇲🇲🇰🇭🇮🇩🇱🇦🇲🇾🇵🇭🇸🇬🇹🇭🇹🇱🇻🇳

🙏 Drs @FredTingMD and Jeremiah Vallente

🔗 https://t.co/TZwDrRoBXJ

[Fred Ting @fredtingmd]

@ASCOPres @ASCO Thank you for your leadership, Dr. Zon! Especially for always emphasizing Inclusion and Diversity in @ASCO! 🙏🩵

[James Wu | 吴简凡 MD @JamesFanWu]

Some of the best parts of #ASCO25 is the opportunity to meet in person your research collaborators from around the world!!

Check one of our groups’ most recent publications on “National Cancer System Characteristics and Global Pan-Cancer Outcomes: https://t.co/1jbecD0JUb

[James Wu | 吴简凡 MD @JamesFanWu]

Finally got my #HearHer pin from @NarjustFlorezMD!

For #lcsm, women have delays in diagnosis & treatment & younger women are diagnosed at greater rates than men!

Women are less likely to be offered #lcsm screening & enrolled in #lcsm clinical trials! #ASCO25

[Edward Christopher "Chris" Dee, MD @EChrisDee]

“No man is an island”

Dr ⁦@FredTingMD⁩ representing the Philippines 🇵🇭 and highlighting the importance for collaboration in clinical care, research, and policy for patients with #cancer